CBD Shows Antibacterial Activity Against Drug-Resistant Hospital Bacteria
CBD demonstrated antibacterial effects against all tested Enterococcus strains, including drug-resistant hospital pathogens, at very low concentrations.
Quick Facts
What This Study Found
CBD displayed antibacterial properties against all 20 tested clinical strains of E. faecalis and E. faecium with MIC values at or below 1 μg/mL. Higher CBD concentrations produced stronger antibacterial effects. Pure CBD and CBD crystals showed statistically lower MICs than CBD oils. E. faecium was more susceptible than E. faecalis.
Key Numbers
MIC ≤ 1 μg/mL for all tested strains. 20 clinical strains tested (E. faecalis and E. faecium). 5 CBD oils and 1 CBD crystal product (99% purity) evaluated. Pure CBD significantly more effective than CBD oils.
How They Did This
Pilot study evaluating antimicrobial effects of five CBD oils and one 99% CBD crystal product against 20 clinical strains of Enterococcus species using the microdilution method in Mueller-Hinton broth to determine Minimal Inhibitory Concentrations.
Why This Research Matters
Enterococcus bacteria are increasingly resistant to conventional antibiotics and cause serious hospital infections. Finding that CBD works against these multidrug-resistant strains at low concentrations opens a potential new avenue in the fight against antibiotic resistance.
The Bigger Picture
Antibiotic resistance is one of the greatest threats to global health. CBD's antibacterial properties against hospital superbugs suggest cannabinoids could become part of future antimicrobial arsenals — though significant development work remains.
What This Study Doesn't Tell Us
In vitro pilot study only — lab conditions don't reflect the complexity of treating infections in living organisms. Small number of strains tested. Mechanism of antibacterial action not elucidated. No toxicity or pharmacokinetic data.
Questions This Raises
- ?What is CBD's mechanism of antibacterial action against Enterococcus?
- ?Would CBD work synergistically with existing antibiotics?
- ?Could CBD-based topical formulations prevent surgical site infections?
Trust & Context
- Key Stat:
- Evidence Grade:
- Pilot in vitro study demonstrates clear antibacterial activity but is far from clinical application. Mechanism and in vivo efficacy unknown.
- Study Age:
- Published 2026, addressing the growing multidrug-resistant Enterococcus crisis.
- Original Title:
- Cannabidiol (CBD) and Other Cannabinoids as a Promising Alternative Antibacterial Agent-Pilot Study on Enterococcus faecalis and Enterococcus faecium Clinical Strains.
- Published In:
- Molecules (Basel, Switzerland), 31(1) (2026)
- Authors:
- Kraszewska, Zuzanna, Grudlewska-Buda, Katarzyna, Wnuk, Kacper, Wałecka-Zacharska, Ewa, Gospodarek-Komkowska, Eugenia, Skowron, Krzysztof
- Database ID:
- RTHC-08400
Evidence Hierarchy
Frequently Asked Questions
Can CBD kill bacteria?
In lab tests, CBD inhibited the growth of all 20 drug-resistant Enterococcus bacteria strains at very low concentrations. However, this is a pilot lab study — it hasn't been tested as a treatment for actual infections.
Is CBD oil as effective as pure CBD against bacteria?
No — pure CBD crystals (99% purity) showed significantly stronger antibacterial effects than CBD oils, suggesting the concentration and purity of CBD matters for antimicrobial activity.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- thc-and-antibiotics-safe-cannabis-while-on
Cite This Study
https://rethinkthc.com/research/RTHC-08400APA
Kraszewska, Zuzanna; Grudlewska-Buda, Katarzyna; Wnuk, Kacper; Wałecka-Zacharska, Ewa; Gospodarek-Komkowska, Eugenia; Skowron, Krzysztof. (2026). Cannabidiol (CBD) and Other Cannabinoids as a Promising Alternative Antibacterial Agent-Pilot Study on Enterococcus faecalis and Enterococcus faecium Clinical Strains.. Molecules (Basel, Switzerland), 31(1). https://doi.org/10.3390/molecules31010144
MLA
Kraszewska, Zuzanna, et al. "Cannabidiol (CBD) and Other Cannabinoids as a Promising Alternative Antibacterial Agent-Pilot Study on Enterococcus faecalis and Enterococcus faecium Clinical Strains.." Molecules (Basel, 2026. https://doi.org/10.3390/molecules31010144
RethinkTHC
RethinkTHC Research Database. "Cannabidiol (CBD) and Other Cannabinoids as a Promising Alte..." RTHC-08400. Retrieved from https://rethinkthc.com/research/kraszewska-2026-cannabidiol-cbd-and-other
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.